EICHOR
● Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Condition: Lymphoma, Large B-Cell, Diffuse · Sponsor: Merck Sharp & Dohme LLC
About this study
Researchers are looking for ways to treat germinal center B-cell-like diffuse large B-cell lymphoma (GCB DLBCL). DLBCL is a fast-growing blood cancer that affects B-cells. GCB is a type of DLBCL that affects young B-cells that are still maturing. The goal of this study is to learn if more people who receive zilovertamab vedotin (MK-2140) and R-CHP have the cancer respond (go away) than those who receive polatuzumab vedotin and R-CHP.
This description comes directly from the study's public registry record.
Talk to the study team
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
Locations (139)
| Infirmary Cancer Care ( Site 0157) | Mobile, Alabama, United States | Recruiting |
| Ironwood Cancer & Research Centers ( Site 0204) | Chandler, Arizona, United States | Recruiting |
| Palo Verde Cancer Specialists ( Site 0105) | Glendale, Arizona, United States | Recruiting |
| City of Hope - Phoenix ( Site 0202) | Goodyear, Arizona, United States | Recruiting |
| Genesis Cancer and Blood Institute ( Site 0193) | Hot Springs, Arkansas, United States | Recruiting |
| Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135) | Burbank, California, United States | Recruiting |
| City of Hope Comprehensive Cancer Center ( Site 0191) | Duarte, California, United States | Recruiting |
| Bass Medical Group ( Site 0123) | Walnut Creek, California, United States | Recruiting |
| Rocky Mountain Cancer Centers (RMCC) ( Site 8001) | Aurora, Colorado, United States | Recruiting |
| Colorado West Healthcare System-Grand Valley Oncology ( Site 0165) | Grand Junction, Colorado, United States | Recruiting |
| Medical Oncology Hematology Consultants (MOHC) ( Site 8007) | Newark, Delaware, United States | Recruiting |
| Georgetown University Medical Center ( Site 0117) | Washington D.C., District of Columbia, United States | Recruiting |
+ 127 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.